4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide

C92H94F8N10O14S3 — CID 167613112

IUPAC4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide
SMILESCc1c(F)c(F)c(F)c(S(=O)(=O)N2CC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cn2)c2cccc(O)c2)c1F.Cc1c(F)c(F)c(S(=O)(=O)N2CCC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cn2)c2ccc3c(=O)[nH]ncc3c2)c(F)c1F.Cc1ccc(S(=O)(=O)N2CC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cc2)c2ccc(C(=O)O)c(O)c2)cc1
InChIInChI=1S/C32H31F4N5O4S.C31H34N2O6S.C29H29F4N3O4S/c1-18-26(33)28(35)30(29(36)27(18)34)46(44,45)41-13-5-8-25(41)32(43)40(23-11-12-24-21(14-23)16-38-39-31(24)42)17-22-10-9-20(15-37-22)19-6-3-2-4-7-19;1-21-7-14-26(15-8-21)40(38,39)33-18-17-28(33)30(35)32(25-13-16-27(31(36)37)29(34)19-25)20-22-9-11-24(12-10-22)23-5-3-2-4-6-23;1-17-24(30)26(32)27(33)28(25(17)31)41(39,40)36-13-12-23(36)29(38)35(21-8-5-9-22(37)14-21)16-20-11-10-19(15-34-20)18-6-3-2-4-7-18/h9-12,14-16,19,25H,2-8,13,17H2,1H3,(H,39,42);7-16,19,23,28,34H,2-6,17-18,20H2,1H3,(H,36,37);5,8-11,14-15,18,23,37H,2-4,6-7,12-13,16H2,1H3/t25-;28-;23-/m111/s1
InChIKeyLISLOXAEKRPOJS-JJOQPPQYSA-N
MW1812.00 g/mol
LogP16.76
Rot. Bonds22

About 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide

4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide (PubChem CID 167613112) has the molecular formula C92H94F8N10O14S3 and a molecular weight of 1812.00 g/mol. Its IUPAC name is 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide.

Molecular Properties

Compound Name4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide
PubChem CID167613112
Molecular FormulaC92H94F8N10O14S3
Molecular Weight1812.00 g/mol
Exact Mass1810.60
IUPAC Name4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide
SMILESCc1c(F)c(F)c(F)c(S(=O)(=O)N2CC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cn2)c2cccc(O)c2)c1F.Cc1c(F)c(F)c(S(=O)(=O)N2CCC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cn2)c2ccc3c(=O)[nH]ncc3c2)c(F)c1F.Cc1ccc(S(=O)(=O)N2CC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cc2)c2ccc(C(=O)O)c(O)c2)cc1
InChIInChI=1S/C32H31F4N5O4S.C31H34N2O6S.C29H29F4N3O4S/c1-18-26(33)28(35)30(29(36)27(18)34)46(44,45)41-13-5-8-25(41)32(43)40(23-11-12-24-21(14-23)16-38-39-31(24)42)17-22-10-9-20(15-37-22)19-6-3-2-4-7-19;1-21-7-14-26(15-8-21)40(38,39)33-18-17-28(33)30(35)32(25-13-16-27(31(36)37)29(34)19-25)20-22-9-11-24(12-10-22)23-5-3-2-4-6-23;1-17-24(30)26(32)27(33)28(25(17)31)41(39,40)36-13-12-23(36)29(38)35(21-8-5-9-22(37)14-21)16-20-11-10-19(15-34-20)18-6-3-2-4-7-18/h9-12,14-16,19,25H,2-8,13,17H2,1H3,(H,39,42);7-16,19,23,28,34H,2-6,17-18,20H2,1H3,(H,36,37);5,8-11,14-15,18,23,37H,2-4,6-7,12-13,16H2,1H3/t25-;28-;23-/m111/s1
InChIKeyLISLOXAEKRPOJS-JJOQPPQYSA-N
XLogP16.76
TPSA322.36 Ų
H-Bond Donors4
H-Bond Acceptors16
Rotatable Bonds22
Heavy Atoms127
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001812.00
LogP ≤ 516.76
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'halogenated_ring_2', 'substructure': 'N/A'}

Analyze 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide?
The IUPAC name of 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide (CID 167613112) is 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide.
What is the SMILES notation for 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide?
The canonical SMILES for 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide is Cc1c(F)c(F)c(F)c(S(=O)(=O)N2CC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cn2)c2cccc(O)c2)c1F.Cc1c(F)c(F)c(S(=O)(=O)N2CCC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cn2)c2ccc3c(=O)[nH]ncc3c2)c(F)c1F.Cc1ccc(S(=O)(=O)N2CC[C@@H]2C(=O)N(Cc2ccc(C3CCCCC3)cc2)c2ccc(C(=O)O)c(O)c2)cc1.
What is the InChIKey of 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide?
The InChIKey is LISLOXAEKRPOJS-JJOQPPQYSA-N. The full InChI is InChI=1S/C32H31F4N5O4S.C31H34N2O6S.C29H29F4N3O4S/c1-18-26(33)28(35)30(29(36)27(18)34)46(44,45)41-13-5-8-25(41)32(43)40(23-11-12-24-21(14-23)16-38-39-31(24)42)17-22-10-9-20(15-37-22)19-6-3-2-4-7-19;1-21-7-14-26(15-8-21)40(38,39)33-18-17-28(33)30(35)32(25-13-16-27(31(36)37)29(34)19-25)20-22-9-11-24(12-10-22)23-5-3-2-4-6-23;1-17-24(30)26(32)27(33)28(25(17)31)41(39,40)36-13-12-23(36)29(38)35(21-8-5-9-22(37)14-21)16-20-11-10-19(15-34-20)18-6-3-2-4-7-18/h9-12,14-16,19,25H,2-8,13,17H2,1H3,(H,39,42);7-16,19,23,28,34H,2-6,17-18,20H2,1H3,(H,36,37);5,8-11,14-15,18,23,37H,2-4,6-7,12-13,16H2,1H3/t25-;28-;23-/m111/s1.
What are the key properties of 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide?
4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide has a molecular weight of 1812.00 g/mol, XLogP of 16.76, 22 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(4-cyclohexylphenyl)methyl-[(2R)-1-(4-methylphenyl)sulfonylazetidine-2-carbonyl]amino]-2-hydroxybenzoic acid;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(3-hydroxyphenyl)-1-(2,3,4,6-tetrafluoro-5-methylphenyl)sulfonylazetidine-2-carboxamide;(2R)-N-[(5-cyclohexyl-2-pyridinyl)methyl]-N-(1-oxo-2H-phthalazin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)sulfonylpyrrolidine-2-carboxamide is sourced from PubChem (CID 167613112), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).